ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0365

Establishing a Multidisciplinary Registry for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis: Insights into Patient Outcomes and Management Challenges

Stacey Tarvin1, Amy Rakestraw2, Jessica Lee2, N. Shaun Matthews3, Susan H. Ballinger2 and Christina M. Sparks2, 1Riley Hospital for Children at Indiana University Health, Indianapolis, IN, 2Indiana University School of Medicine, Indianapolis, IN, 3Indiana University School of Dentistry, Indianapolis, IN

Meeting: ACR Convergence 2023

Keywords: Cohort Study, Disease Activity, Juvenile idiopathic arthritis, Patient reported outcomes, Temporomandibular joint

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0345–0379) Pediatric Rheumatology – Clinical Poster I: JIA

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Temporomandibular joint (TMJ) arthritis, a condition frequently overlooked in patients with JIA, can result in joint damage if not promptly treated. Such damage presents as pain during joint movement and chewing, as well as mandibular growth abnormalities. Due to minimal symptoms in the early stages, timely diagnosis of TMJ arthritis is challenging without early imaging, often leading to joint damage before detection. This study aims to establish a registry specifically focusing on JIA patients with TMJ involvement. The registry operates within a multidisciplinary clinic, involving pediatric rheumatologists, neuroradiologists, oral maxillofacial surgeons, physical therapists, orthodontists, and pediatric dentists.

Methods: The study enrolled JIA patients referred to the multidisciplinary TMJ clinic for suspected TMJ involvement. Data collection took place during routine care visits, and information was obtained through a combination of prospective and retrospective chart reviews, as well as patient-reported outcomes. The data analyzed in this study were extracted from the participants’ initial visit records. Quantitative data was analyzed using descriptive statistics.

Results: Data from the multidisciplinary TMJ clinic were reviewed involving (n=30) 7 males and 23 females aged 7 to 20 years. The most common diagnoses among participants were polyarticular JIA (30%), oligoarticular JIA (23.3%), and enthesitis-related arthritis (16%) [Figure 1]. The primary reason for referral to the TMJ clinic was jaw, muscle, or neck pain, reported by 86.7% of participants. Before the referral, participants had, on average, tried 2.8 different treatment agents [Figure 2]. Furthermore, 23.3% of participants had received prior TMJ steroid injections, and 13.3% had undergone a prior TMJ wash-out. Among the 30 patients, 21 had obtained an MRI of their TM joint within 12 months of entering the clinic. During the study visit, participants completed the Pediatric Quality of Life Inventory, a measure of health-related quality of life (HRQOL). The responses were transformed to a 0-100 scale, with higher scores indicating better HRQOL. The average score across all categories (daily activities, pain and hurt, treatment, worry, and communication) was 66.4 [Figure 3]. Participants also reported difficulties in performing various activities based on a patient-specific functional scale. A total of 56 activities were identified, and on average, patients scored 4.9 per activity on a scale of 0 to 10, with 0 indicating complete inability to perform the activity. Overall, participants reported an average pain intensity score of 3.4/10, and 64% of patients reported affected functionality of their jaws. Additionally, 8 out of the 30 study participants expressed concerns regarding body image.

Conclusion: This data offers valuable insights by capturing outcomes from patients with TMJ arthritis. Our findings indicate that these patients endure TMJ-related pain and experience joint dysfunction that affects their quality of life. The challenges associated with TMJ arthritis highlight the importance of this registry and the ongoing observation of this clinic’s cohort.

Supporting image 1

Percentage of JIA subtypes in TMJ clinic cohort.

Supporting image 2

Treatment agent usage within TMJ clinic cohort.

Supporting image 3

Health-related quality of life scores by category.


Disclosures: S. Tarvin: Pfizer, 5, Roche, 5, UCB, 5; A. Rakestraw: None; J. Lee: None; N. Matthews: None; S. Ballinger: None; C. Sparks: None.

To cite this abstract in AMA style:

Tarvin S, Rakestraw A, Lee J, Matthews N, Ballinger S, Sparks C. Establishing a Multidisciplinary Registry for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis: Insights into Patient Outcomes and Management Challenges [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/establishing-a-multidisciplinary-registry-for-temporomandibular-joint-arthritis-in-juvenile-idiopathic-arthritis-insights-into-patient-outcomes-and-management-challenges/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/establishing-a-multidisciplinary-registry-for-temporomandibular-joint-arthritis-in-juvenile-idiopathic-arthritis-insights-into-patient-outcomes-and-management-challenges/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology